{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Atropine+0.1%25+Ophthalmic+Solution", "query": { "intervention": "Atropine 0.1% Ophthalmic Solution" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 5, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-27T13:06:54.442Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03544827", "title": "The Effects of Low Dose Atropine on Choroidal Thickness", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Myopia" ], "interventions": [ { "name": "Atropine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "State University of New York College of Optometry", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 36, "start_date": "2018-05-21", "completion_date": "2019-02-08", "has_results": false, "last_update_posted_date": "2019-02-15", "last_synced_at": "2026-09-27T13:06:54.442Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03544827" }, { "nct_id": "NCT00748059", "title": "The Pathophysiology of Orthostatic Hypotension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Autonomic Nervous System Diseases", "Orthostatic Hypotension", "Dopamine Beta-Hydroxylase Deficiency", "Orthostatic Intolerance" ], "interventions": [ { "name": "Standing or upright tilt", "type": "PROCEDURE" }, { "name": "Microneurography", "type": "PROCEDURE" }, { "name": "QSweat", "type": "PROCEDURE" }, { "name": "neck cuff stimulation", "type": "DEVICE" }, { "name": "phenylephrine,isoproterenol,nitroprusside,propranolol,edrophonium,atropine,tyramine", "type": "DRUG" }, { "name": "clonidine,yohimbine,metoclopramide,alpha-methyldopa", "type": "DRUG" }, { "name": "BodPod", "type": "PROCEDURE" }, { "name": "Eye exam", "type": "PROCEDURE" }, { "name": "Sleep study", "type": "PROCEDURE" }, { "name": "Pain response testing", "type": "PROCEDURE" }, { "name": "Metabolic chamber", "type": "PROCEDURE" }, { "name": "Brain function studies", "type": "PROCEDURE" }, { "name": "Bicycle Exercise Test", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DEVICE", "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "12 Years to 70 Years" }, "enrollment_count": 10, "start_date": "1996-12", "completion_date": "2020-12", "has_results": false, "last_update_posted_date": "2021-05-12", "last_synced_at": "2026-09-27T13:06:54.442Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00748059" }, { "nct_id": "NCT04290039", "title": "Sublingual vs IV Atropine Bioavailability Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Toxic Effect of Organophosphate and Carbamate Insecticides" ], "interventions": [ { "name": "Atropine Sulfate Ophthalmic Solution", "type": "DRUG" }, { "name": "Atropine Sulphate Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biomedical Advanced Research and Development Authority", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 15, "start_date": "2020-01-04", "completion_date": "2020-02-08", "has_results": true, "last_update_posted_date": "2023-06-22", "last_synced_at": "2026-09-27T13:06:54.442Z", "location_count": 1, "location_summary": "High Point, North Carolina", "locations": [ { "city": "High Point", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04290039" }, { "nct_id": "NCT05331664", "title": "Dropless Pars Plana Vitrectomy Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Rhegmatogenous Retinal Detachment" ], "interventions": [ { "name": "Pars plana vitrectomy", "type": "PROCEDURE" }, { "name": "Triamcinolone Acetonide 40mg/mL", "type": "DRUG" }, { "name": "Moxifloxacin 0.5% or Polymyxin/Trimethoprim if patient is allergic to moxifloxacin", "type": "DRUG" }, { "name": "Prednisolone 1%", "type": "DRUG" }, { "name": "Atropine 1%", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Massachusetts Eye and Ear Infirmary", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 168, "start_date": "2022-07-25", "completion_date": "2026-08-30", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-09-27T13:06:54.442Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05331664" }, { "nct_id": "NCT03942419", "title": "Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Myopia" ], "interventions": [ { "name": "Atropine 0.1% Ophthalmic Solution", "type": "DRUG" }, { "name": "Atropine 0.01% Ophthalmic Solution", "type": "DRUG" }, { "name": "Placebo Ophthalmic Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eyenovia Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "3 Years to 12 Years" }, "enrollment_count": 438, "start_date": "2019-06-03", "completion_date": "2024-11-20", "has_results": false, "last_update_posted_date": "2025-01-06", "last_synced_at": "2026-09-27T13:06:54.442Z", "location_count": 18, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Azusa, California + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Azusa", "state": "California" }, { "city": "Berkeley", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03942419" } ] }